2016
Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma
NORTON, Pamela, Mary Ann COMUNALE, Harmin HERRERA, Mengjun WANG, Josef HOUSER et. al.Základní údaje
Originální název
Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma
Autoři
NORTON, Pamela (840 Spojené státy), Mary Ann COMUNALE (840 Spojené státy), Harmin HERRERA (840 Spojené státy), Mengjun WANG (840 Spojené státy), Josef HOUSER (203 Česká republika, domácí), Michaela WIMMEROVÁ (203 Česká republika, garant, domácí), Patrick R ROMANO (840 Spojené státy) a Anand MEHTA (356 Indie)
Vydání
Proteomics, HOBOKEN, Wiley-Blackwell, 2016, 1615-9853
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.041
Kód RIV
RIV/00216224:14740/16:00088672
Organizační jednotka
Středoevropský technologický institut
UT WoS
000390809000010
Klíčová slova anglicky
Aleuria aurantia lectin; Biomarker; Glycoproteomics; Glycosylation; Hepatocellular carcinoma; Liver cancer
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 14. 3. 2017 13:06, Mgr. Eva Špillingová
Anotace
V originále
The Aleuria aurantia lectin (AAL) derived from orange peel fungus contains five fucose-binding sites that recognizes fucose bound in -1,2, -1,3, -1,4, and -1,6 linkages to N-acetylglucosamine and galactose. Recently, we have created several recombinant AAL (rAAL) proteins that had altered binding affinity to fucose linkages. In this report, we further characterize the binding specificity of one of the mutated lectins, N224Q lectin. This lectin was characterized by lectin Western blotting, surface plasmon resonance, and glycan microarray and shown to have increased binding to fucosylated glycan. Subsequently, we used this lectin to identify secreted fucosylated glycoproteins from a fetal hepatic cell line. Proteomic analysis revealed several glycoproteins secreted by the fetal cell line that were bound by N224Q lectin. These findings were confirmed by subsequent proteomic analysis of human serum from control patients or patients with hepatocellular carcinoma. These represent candidate oncofetal markers for liver cancer.
Návaznosti
GA13-25401S, projekt VaV |
| ||
LQ1601, projekt VaV |
|